OncoSpan is Horizon’s largest Reference Standard, which features 386 variants across 152 key cancer genes. All our Reference Standards are cell line-derived for the closest representation of your patient sample. You also have access to batch-specific NGS data for all variants, providing you with a high-quality truth set to give you consistency, confidence and control over your assays. OncoSpan is supported by a bespoke quality control platform, OncoMatic, for comprehensive and easy assay validation of oncology gene panels and exome sequencing assays.
Company Info:
Horizon Discovery combines deep scientific experience in translational research with a precision gene-editing platform incorporating rAAV, CRISPR and ZFN technologies. Horizon supplies genetically-defined cell lines, in vivo models, custom cell line generation, molecular reference standards, and contract research services to over 1,000 academic, clinical and biopharmaceutical organizations.
Contact Information:
8100 Beach Drive, Cambridge Research Park, Waterbeach, Cambridge CB25 9TL
Phone: 01223 976000
Email: info@horizondiscovery.com
